Description

DILVAS 10 MG

Indications

DILVAS 10 MG is primarily indicated for the management of hypertension and the treatment of chronic stable angina pectoris. It is also utilized in certain cases of heart failure, particularly when combined with other therapeutic agents. The active ingredient in DILVAS is amlodipine, which belongs to the class of medications known as calcium channel blockers. This medication is prescribed to help lower blood pressure and improve blood flow to the heart, thereby reducing the risk of cardiovascular events.

Mechanism of Action

The therapeutic effects of DILVAS 10 MG are attributed to its active component, amlodipine. Amlodipine functions by inhibiting the influx of calcium ions into vascular smooth muscle and cardiac muscle cells. This calcium blockade leads to relaxation of the vascular smooth muscle, resulting in vasodilation and a subsequent decrease in peripheral vascular resistance. Consequently, this lowers blood pressure and alleviates the workload on the heart, making it easier for the heart to pump blood. Additionally, by improving coronary blood flow, amlodipine helps relieve angina symptoms.

Pharmacological Properties

DILVAS 10 MG exhibits several pharmacological properties that contribute to its effectiveness in treating cardiovascular conditions. Amlodipine has a long half-life, allowing for once-daily dosing, which enhances patient compliance. It is well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring approximately 6 to 12 hours after administration. The drug is extensively metabolized in the liver, primarily via the cytochrome P450 system, and is excreted as metabolites in the urine. Its pharmacokinetic profile supports its use in both acute and chronic management of hypertension and angina.

Contraindications

DILVAS 10 MG is contraindicated in patients with a known hypersensitivity to amlodipine or any of the excipients in the formulation. It should not be used in patients with severe hypotension or cardiogenic shock, as these conditions may be exacerbated by the vasodilatory effects of the medication. Additionally, caution is advised in patients with aortic stenosis, as the drug may lead to further compromise of cardiac output.

Side Effects

While DILVAS 10 MG is generally well tolerated, some patients may experience side effects. Common adverse reactions include peripheral edema, dizziness, fatigue, and palpitations. Less frequently, patients may report nausea, abdominal pain, flushing, or headache. Serious side effects, although rare, can include hypotension, worsening angina, or myocardial infarction. Patients are advised to report any unusual or severe symptoms to their healthcare provider promptly.

Dosage and Administration

The recommended starting dose of DILVAS 10 MG for adults is one tablet taken orally once daily. Depending on the patient’s response and clinical condition, the dose may be adjusted. The maximum recommended dose is 10 MG per day. It is important to take DILVAS at the same time each day to maintain consistent blood levels of the medication. Patients should be advised to swallow the tablet whole, without crushing or chewing, and to take it with or without food.

Interactions

DILVAS 10 MG may interact with other medications, which can alter its effectiveness or increase the risk of adverse effects. Notable interactions include those with other antihypertensive agents, as concurrent use may lead to additive hypotensive effects. Caution is also warranted when using DILVAS with medications that affect hepatic enzymes, such as CYP3A4 inhibitors or inducers, as these can influence amlodipine metabolism. Patients should inform their healthcare provider of all medications, supplements, and herbal products they are taking to avoid potential interactions.

Precautions

Before initiating treatment with DILVAS 10 MG, healthcare providers should evaluate patients for any pre-existing conditions that may affect the safety or efficacy of the medication. Special caution is advised in patients with hepatic impairment, as dose adjustments may be necessary. Patients with a history of heart failure should be monitored closely during treatment, as the medication may exacerbate their condition. It is also important to assess renal function prior to and during therapy, as renal impairment may alter drug clearance.

Clinical Studies

Clinical studies have demonstrated the efficacy of DILVAS 10 MG in managing hypertension and angina. In randomized controlled trials, amlodipine has been shown to significantly reduce systolic and diastolic blood pressure compared to placebo. Furthermore, studies have indicated that DILVAS can improve exercise tolerance and reduce the frequency of angina attacks in patients with stable angina pectoris. Long-term studies have also suggested that amlodipine may have a favorable impact on cardiovascular outcomes, including a reduction in the incidence of myocardial infarction and stroke.

Conclusion

DILVAS 10 MG is a valuable therapeutic option for patients with hypertension and chronic stable angina. Its mechanism of action, pharmacological properties, and clinical efficacy support its use in managing cardiovascular conditions. However, as with any medication, it is essential for patients to be aware of potential side effects, contraindications, and drug interactions. Regular follow-up with healthcare providers is crucial to ensure optimal treatment outcomes and to make necessary adjustments to therapy.